Reviva Pharmaceuticals Holding - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
RVPH Nasdaq 8731 https://revivapharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Reviva Pharmaceuticals Holding

Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia - Apr 15th, 2024 12:30 pm
Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights - Apr 15th, 2024 12:05 pm
RVPH: Update to Brilaroxazine Safety vs. Efficacy Comparison – Adding RECOVER Data - Apr 15th, 2024 11:06 am
Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the SIRS 2024 Annual Meeting - Mar 28th, 2024 12:00 pm
Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the ASCPT 2024 Annual Meeting - Mar 26th, 2024 12:00 pm
Reviva to Present at the UBS Virtual CNS Day - Mar 11th, 2024 12:00 pm
Reviva to Present at the 36th Annual ROTH Conference - Mar 7th, 2024 1:00 pm
Reviva Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference - Feb 20th, 2024 1:00 pm
Reviva to Host KOL Event to Discuss Topline Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia - Feb 6th, 2024 1:00 pm
Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference - Jan 25th, 2024 1:00 pm
Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs - Jan 23rd, 2024 12:32 pm
Reviva to Present at Webull LIVE! Healthcare Webinar on January 17 - Jan 10th, 2024 1:00 pm
Reviva Provides Corporate and Program Updates and Highlights Key Upcoming Milestones - Jan 4th, 2024 1:00 pm
Karuna downgraded, Arm target raised: Wall Street's top analyst calls - Dec 26th, 2023 3:04 pm
Life Science Investor Forum: Presentations Now Available for Online Viewing - Dec 15th, 2023 1:35 pm
Life Science Investor Forum Agenda Announced for December 14th, 2023 - Dec 12th, 2023 6:02 pm
Reviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum - Dec 11th, 2023 1:35 pm
Reviva Pharmaceuticals to Participate in The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference - Nov 30th, 2023 9:05 pm
Reviva Announces Closing of $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Nov 20th, 2023 9:05 pm
RVPH: Raise & RECOVER Results Review - Nov 20th, 2023 11:38 am